---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-075697"
form_type: "8-K"
ticker: "ONCO"
cik: "0001782107"
company_name: "Onconetix, Inc."
filed_at: "2024-09-05T23:59:59+00:00"
generated_at: "2026-05-31T06:17:04.554423+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Onconetix shareholders to vote on Series B conversion, $5M financing at Sept 5 meeting

## Summary
- Annual meeting on Sept 5, 2024; vote on conversion of 269.7M shares from Series B Preferred and $5M PMX private placement.
- Pro forma shows Series B conversion eliminates $64.2M carrying value of preferred stock and adds 269.7M common shares.
- Pro forma also reflects settlement of $5M related party debenture via 20.5M shares and PIO exercise netting $922,749.
- If approved, conversion triggers a change of control, requiring full compliance with Nasdaq initial listing criteria.
- Pro forma weighted average shares outstanding would be 325.5M vs 22.2M actual; net loss per share widens to $0.08.

## SEC filing metadata
- accession: 0001213900-24-075697
- form_type: 8-K
- ticker: ONCO
- cik: 0001782107
- company_name: Onconetix, Inc.
- filed_at: 2024-09-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782107/000121390024075697/0001213900-24-075697-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782107/000121390024075697/ea0213522-8k_onconetix.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-075697
- JSON: https://secwatch.observer/filing/0001213900-24-075697.json
- Plain text: https://secwatch.observer/filing/0001213900-24-075697.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.